HOME > BUSINESS
BUSINESS
- Additional OS Data to Be Added to Xospata’s US Label: Astellas
June 3, 2019
- Biogen to Leverage Aducanumab Learnings, Spinraza to Remain Foundation of SMA Care: Japan Chief
June 3, 2019
- Takeda Shareholders Pitch Claw-Back Clause, Urge Execs to Return Pay If Loss Incurred on Big Investment
May 31, 2019
- Novartis, Sumitomo Dainippon to Jointly Promote Equa, EquMet
May 31, 2019
- Teva Takeda Yakuhin Voluntary Recalls Menatetrenone Capsules
May 31, 2019
- Application for Mitsubishi Tanabe’s ALS Drug Pulled in EU
May 31, 2019
- Ono Files Opdivo for Second-Line Treatment of Esophageal Cancer
May 31, 2019
- Otsuka Shoots for Pharma Sales of 1.08 Trillion Yen in 2023
May 31, 2019
- Tokyo Court Dismisses Genentech’s Bid to Block Rituxan Biosimilar
May 30, 2019
- Japan Drug Firms’ Average Overseas Sales Ratio Nearly 50%, Offshore Biz Remains Way to Go as Home Market Falters: Tally
May 30, 2019
- Japan’s 1st ADA Deficiency Treatment Revcovi Now Available: Teijin Pharma
May 30, 2019
- Janssen Launches Simponi Autoinjector in Japan, Mitsubishi Tanabe in Charge of Distribution
May 30, 2019
- MSD/Bayer’s Rosuzet Now Available in Japan
May 29, 2019
- Takeda to Launch New Manufacturing Facility for Leuplin; Aims to Maintain Its 110 Billion Yen Sales
May 29, 2019
- Insulin/GLP-1 Receptor Agonist Combo Demonstrates Efficacy in Japan PIII: Sanofi
May 29, 2019
- NEC Ties Up with French Biotech to Develop Neoantigen Vaccines Using AI
May 28, 2019
- Ribomic Files Patent for Aptamer Therapeutic, Ends Licensing Pact with Otsuka
May 27, 2019
- Hisamitsu’s Hyperhidrosis Drug Hit Main Goal in Japan PII
May 27, 2019
- Hisamitsu One Step Closer to FY2019 Filing after NSAID Patch Delivers Positive PIII in Cancer Pain
May 27, 2019
- AbbVie’s Psoriasis Drug Skyrizi Makes Debut in Japan
May 27, 2019
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
